Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy associates early hospital discharge, automated O2 flow weaning with FreeO2 system, telemedicine and tele-rehabilitation.
The main hypothesis of this study is that the FreeDom strategy will reduce the number of hospitalization day by 50 percent at day 30.
The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy will enable an early return home, patients using an innovative device that automatically adjusts and wean the oxygen flow (FreeO2 system) coupled to telemedicine and tele-rehabilitation.
The main hypothesis of this study is that a strategy for an early return home with a home hospitalization managed by telemedicine will reduce the length of hospitalization by 50 percent from 30 days.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | Other | The intervention is an hospitalization with usual care. The hospitalization will take place in the usual setting and the hospital discharge will be decided by pulmonologists according to the usual criteria |
|
| FreeDom | Active Comparator | FreeDom strategy (early discharge, automated weaning at home, telemedicine, telereadaptation): -initial conventional hospitalization before discharge home, O2 flow rate automatically titrated by FreeO2 (based on a SpO2 target). The hospital discharge will be possible if the definite criteria are met. After hospital discharge, patient will have home hospitalisation. Automated oxygen flow titration, patient education will be conducted for using the telemedicine system, for questionnaires and for the tele-rehabilitation program will be initiated for home hospitalization, |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Control | Other | The hospitalization will take place in the usual setting and the hospital discharge will be decided by pulmonologists according to the usual criteria |
|
| Measure | Description | Time Frame |
|---|---|---|
| The number of hospital days during COPD exacerbation at day 30. | The objective of the study is to reduced the hospitalisation days by 50 % at day 30 during COPD exacerbation | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of Emergency consultation and hospital readmission | Rate of Emergency consultation and hospital readmission | 1 and 3 months |
| Health Related Quality of Life | Survey of health related quality of life |
Not provided
Inclusion Criteria:
All patients hospitalized for COPD exacerbation for less than 48 hours will be considered.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| François Lellouche | Contact | 418-656-8711 | 3572 | francois.lellouche@criucpq.ulaval.ca |
| Pierre-alexandre Bouchard | Contact | 418-656-8711 | 2712 | pierre-alexandre.bouchard@criucpq.ulaval.ca |
| Name | Affiliation | Role |
|---|---|---|
| François Lellouche | Laval University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institut Universitaire de Cardiologie et de Pneumologie de Québec | Recruiting | Québec | G1V4G5 | Canada |
Not provided
| ID | Term |
|---|---|
| D000860 | Hypoxia |
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D008173 | Lung Diseases, Obstructive |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| FreeDom | Device | Early return home, patients using an innovative device that automatically adjusts and wean the oxygen flow (FreeO2 system) coupled to telemedicine and tele-rehabilitation |
|
|
| 1 and 3 months |
| Cost of care at 3 months | Economic evaluation about these 2 different strategy of COPD exacerbation management using micro-costing approach and including the cost of the FreeO2 technology | 3 months |
| Oxygenation data (% of time in the SpO2 target, % of time with hypoxemia, % of time with hyperoxia) | The continuous measurement of SpO2 and O2 flow rate with the FreeO2 device (only in the FreeDom strategy) will allow the calculation of the % of time within the SpO2 target (recorded in the FreeO2) ± 2%, with hypoxemia (% of time with SpO2 < 85%) and with hyperoxia (% of time above SpO2 target +5%) | From inclusion to hospital discharge and from hospital discharge to the end of oxygen therapy (around one week after discharge) |
| Number of consultations | Number of consultation : phone call, video consultation, rehabilitation, home visit | 3 months |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |